NOVAST Laboratories, Limited (SHE:301569)
15.01
-1.02 (-6.36%)
Nov 20, 2026, 3:04 PM CST
| Market Cap | 13.38B |
| Revenue (ttm) | 1.01B +16.6% |
| Net Income | 311.22M +19.6% |
| EPS | 0.41 +20.4% |
| Shares Out | 891.60M |
| PE Ratio | 36.68 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,544,954 |
| Open | 19.25 |
| Previous Close | 16.03 |
| Day's Range | 15.01 - 19.25 |
| 52-Week Range | 15.01 - 42.15 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 17, 2026 |